{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:27Z","timestamp":1753892007220,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sensory input mismatches among the vestibular system, autonomic control, and visual perception cause motion sickness. Anticholinergics and antihistamines are commonly used but have limited efficacy and cause significant side effects. Orexin-A, a hypothalamic neuropeptide, has recently garnered attention for its potential role in controlling motion sickness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To summarize current knowledge on the effects and mechanisms of orexin-A in reducing motion sickness, identify gaps, and propose future research directions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Five qualified animal experiments were identified after searching PubMed, Scopus, Cochrane Library, Embase, and WoS. The SYRCLE tool was used to evaluate study quality, followed by a qualitative synthesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Orexin-A reduced motion-induced behavioral abnormalities, nausea, and vomiting in rat and cat models. These benefits are likely mediated by the modulation of hypothalamic nuclei activity, enhanced stomach motility, and improved vestibular function. However, several limitations were observed, including inadequate reporting on randomization, blinding, and allocation concealment, as well as heterogeneity in interventions and outcome measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Animal model studies indicates that orexin-A mitigates motion sickness (MS) symptoms in animal models, but overall certainty is low to moderate owing to risk of bias and indirectness. Rigorous, blinded studies with standardized outcomes\u2014and ultimately, early-phase clinical trials, are needed to clarify therapeutic potential.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1624080","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:26:04Z","timestamp":1751261164000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Orexin-A and motion sickness: a systematic review of animal model studies"],"prefix":"10.3389","volume":"16","author":[{"given":"Xu","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e2383232024","DOI":"10.1523\/JNEUROSCI.2383-23.2024","article-title":"Orexin facilitates the peripheral chemoreflex via corticotropin-releasing hormone neurons projecting to the nucleus of the solitary tract","volume":"44","author":"Ben Musa","year":"2024","journal-title":"J. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.autneu.2006.07.019","article-title":"Motion sickness susceptibility","volume":"129","author":"Golding","year":"2006","journal-title":"Auton. Neurosci-Basic"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3389\/fphys.2018.01811","article-title":"Arcuate nucleus orexin-a signaling alleviates cisplatin-induced nausea and vomiting through the paraventricular nucleus of the hypothalamus in rats","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neures.2018.06.001","article-title":"Effect of orexin-A in the arcuate nucleus on cisplatin-induced gastric side effects in rats","volume":"143","author":"Guo","year":"2019","journal-title":"Neurosci. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.autneu.2006.07.014","article-title":"Space motion sickness: incidence, etiology, and countermeasures","volume":"129","author":"Heer","year":"2006","journal-title":"Auton. Neurosci-Basic."},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"Bmc Med. Res. Methodol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD012715","DOI":"10.1002\/14651858.CD012715.pub2","article-title":"Antihistamines for motion sickness","volume":"10","author":"Karrim","year":"2022","journal-title":"Cochrane Db Syst. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"Plos Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/edrv.23.1.0454","article-title":"Orexins in the brain-gut axis","volume":"23","author":"Kirchgessner","year":"2002","journal-title":"Endocr. Rev."},{"key":"B10","article-title":"Orexin projections and localization of orexin receptors","volume-title":"The orexin\/hypocretin system: physiology and pathophysiology","author":"Marcus","year":"2005"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1536","DOI":"10.1002\/wsbm.1536","article-title":"Orexin, serotonin, and energy balance","volume":"14","author":"Mavanji","year":"2022","journal-title":"Wires Mech. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3389\/fpsyg.2014.00997","article-title":"Orexin-A controls sympathetic activity and eating behavior","volume":"5","author":"Messina","year":"2014","journal-title":"Front. Psychol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1440-1746.2011.06626.x","article-title":"Role of brain orexin in the pathophysiology of functional gastrointestinal disorders","volume":"26","author":"Okumura","year":"2011","journal-title":"J. Gastroen Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj-Brit Med. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fnins.2016.00355","article-title":"Evidence for a role of orexin\/hypocretin system in vestibular lesion-induced locomotor abnormalities in rats","volume":"10","author":"Pan","year":"2016","journal-title":"Front. Neurosci-Switz"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/bph.16307","article-title":"Orexin-A attenuated motion sickness through modulating neural activity in hypothalamus nuclei","volume":"181","author":"Pan","year":"2024","journal-title":"Brit J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/jpm13050732","article-title":"Motorist\u2019s vestibular disorientation syndrome (MVDS)-proposed diagnostic criteria","volume":"13","author":"Pawar","year":"2023","journal-title":"J. Pers. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1846","DOI":"10.7205\/MILMED-D-17-00029","article-title":"Management of sea sickness in susceptible flight crews","volume":"182","author":"Powell-Dunford","year":"2017","journal-title":"Mil. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/00001756-200206120-00001","article-title":"Roles of orexins in regulation of feeding and wakefulness","volume":"13","author":"Sakurai","year":"2002","journal-title":"Neuroreport"},{"key":"B21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.smrv.2004.07.006","article-title":"Non-sleep effects of hypocretin\/orexin","volume":"9","author":"Samson","year":"2005","journal-title":"Sleep. Med. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1017\/s0001566000000660","article-title":"Prevalence and correlates of susceptibility to motion sickness","volume":"46","author":"Sharma","year":"1997","journal-title":"Acta Genet. Med. Gemellol. (Roma)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e34009","DOI":"10.7759\/cureus.34009","article-title":"Physiological role of orexin\/hypocretin in the human body in motivated behavior: a comprehensive review","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus J Med Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fnins.2020.00691","article-title":"Evolution of orexin neuropeptide system: structure and function","volume":"14","author":"Soya","year":"2020","journal-title":"Front. Neurosci-Switz"},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00415-018-8961-1","article-title":"Prevalence of motion sickness in various vestibular disorders: a study on 749 patients","volume":"265","author":"Strupp","year":"2018","journal-title":"J. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.peptides.2013.04.019","article-title":"The gene expression of the hypothalamic feeding-regulating peptides in cisplatin-induced anorexic rats","volume":"46","author":"Yoshimura","year":"2013","journal-title":"Peptides"},{"key":"B28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.22038\/ijbms.2020.47599.10973","article-title":"Prevention of cisplatin-induced nausea and vomiting by seabuckthorn (Hippophae rhamnoides L.) seed oil: insights at the level of orexin-a in rats","volume":"24","author":"Yuan","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/cns.12468","article-title":"Motion sickness: current knowledge and recent advance","volume":"22","author":"Zhang","year":"2016","journal-title":"Cns Neurosci. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1624080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:26:05Z","timestamp":1751261165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1624080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":29,"alternative-id":["10.3389\/fphar.2025.1624080"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1624080","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"article-number":"1624080"}}